Avidity (RNA) Is Rising After Collaboration Expansion Move
In today’s assessment of the US stock charts, Avidity Biosciences, Inc. (NASDAQ: RNA) exhibited a notable surge of 11.04%, reaching $6.84 in the current session. This uptick in Avidity’s stock value is attributable to an expansion move in collaboration. Avidity (RNA) has formally disclosed a comprehensive licensing and research collaboration with Bristol Myers Squibb, signaling […]
Avidity (RNA) Is Rising After Collaboration Expansion Move Read More »